Hepatitis C is the leading cause of chronic liver disease and liver cancer in the world and affects an estimated 51 million people globally. Though the viral infection is easily diagnosable and ...

Up to 40% of organizations report ‘major impacts’ on their work, according to surveys by the Coalition for Global Hepatitis ...

Figure 1. The direct-acting antiviral targets in the hepatitis C virus replication cycle. NS3/4A protease inhibitors target the NS3/4A protease enzyme which is needed for the virus to develop the ...

Viral hepatitis is an infection of the liver with one of five strains of the hepatitis virus (A, B, C, D, or E), resulting in liver inflammation and damage. Hepatitis ...

Hepatitis A and hepatitis B can be prevented with vaccines. CDC recommends all eligible gay and bisexual men get vaccinated ...

New medications called direct-acting antivirals (DAAs) have transformed the treatment of hepatitis C. Twelve weeks on one of these drugs cures the infection in 95 percent or more of people who take it ...

Whether hepatitis resolves depends on the type and whether a person receives treatment. Hepatitis A usually resolves without medications, and while sometimes hepatitis B and C may last only a few ...

Person-to-person transmissions of hepatitis A have occurred across the United States and many are affecting gay and bisexual men. Hepatitis A outbreaks among MSM have been reported frequently despite ...

In India, millions of people are living with hepatitis B or C and don’t even know it. You could feel completely fine, go to ...